FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063195 [Registered on: 27/02/2024] Trial Registered Prospectively
Last Modified On: 17/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia
Dentistry 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   Comparison of healing of platelet concentrates one in gel form and one in membrane form after gingival depigmentation 
Scientific Title of Study   Comparative evaluation of application of platelet rich fibrin (PRF) membrane and platelet rich fibrin matrix (PRFM) gel on healing after gingival depigmentation - A clinical and histological study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aditi Dodal 
Designation  postgraduate student 
Affiliation  Dr HSRSM Dental College and Hospital 
Address  Room no 15 Department of Periodontics Dr HSRSM Dental College and Hospital, Basamba Phata, Akola Road, Hingoli.

Hingoli
MAHARASHTRA
431513
India 
Phone  9420877609  
Fax    
Email  aditi.dodal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anup Shelke 
Designation  Professor 
Affiliation  Dr HSRSM Dental College and Hospital 
Address  Room no 15 Department of Periodontics Dr HSRSM Dental College and Hospital, Basamba Phata, Akola Road, Hingoli.

Hingoli
MAHARASHTRA
431513
India 
Phone  9420877609  
Fax    
Email  dranup001@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Aditi Dodal 
Designation  postgraduate student 
Affiliation  Dr HSRSM Dental College and Hospital 
Address  Room no 15 Department of Periodontics Dr HSRSM Dental College and Hospital, Basamba Phata, Akola Road, Hingoli.

Hingoli
MAHARASHTRA
431513
India 
Phone  9420877609  
Fax    
Email  aditi.dodal@gmail.com  
 
Source of Monetary or Material Support  
Dr HSRSM Dental College and Hospital 
 
Primary Sponsor  
Name  Dr Aditi A Dodal 
Address  Dr HSRSM Dental College and Hospital Basamba phata Akola road Hingoli 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aditi A Dodal  Dr HSRSM Dental College and Hospital  Room no 15 Department of Periodontics
Hingoli
MAHARASHTRA 
9420877609

aditi.dodal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr HSRSM Dental College Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K069||Disorder of gingiva and edentulousalveolar ridge, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  platelet rich fibrin (PRF) membrane  Healing after 3 month evaluation on application of platelet rich fibrin (PRF) membrane on gingival depigmentation 
Comparator Agent  platelet rich fibrin matrix (PRFM) gel  Healing after 3 month evaluation on application of platelet rich fibrin matrix (PRFM) gel on gingival depigmentation 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  patient with esthetic concern due to gingival hyperpigmentation
patient with good oral hygiene with plaque index score less than 1 and gingival index score less than 1 and more than 2mm of attached gingiva
Diffuse continuous physiological pigmentation of the gingiva involving the facial aspect of teeth classified under Dummet Oral Pigmentation Index minimum score 2 as Moderate clinical pigmentation 
 
ExclusionCriteria 
Details  Patients suffering from any known systemic diseases
Individuals with a habit of smoking or tobacco chewing
Alcoholic patients
Pregnant and lactating mothers
Patients suffering from neurological deficiency 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Healing based on clinical and histological examination  On 5th day after treatment evaluation of
Visual analogue scale
Healing index Epithelialization test
Punch biopsy 
 
Secondary Outcome  
Outcome  TimePoints 
Healing based on clinical examination  After 3 months of treatment evaluation of
Visual analogue scale
Healing index 
 
Target Sample Size   Total Sample Size="42"
Sample Size from India="42" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   06/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

AIM OF THE STUDY

The aim of this study is to evaluate and compare the clinical and histological effects of platelet rich fibrin (PRF) membrane and platelet rich fibrin matrix (PRFM) gel application on healing after gingival depigmentation.

I. STUDY DESIGN:

This is the double blind nonrandomized interventional study.

II.STUDY SETTING:

A total of 42 sites from 14 patients of Outpatient Department, Department of Periodontics, at Dr HSRSM Dental College and Hospital will be included in the study with prior informed and written consent.

III. STUDY POPULATION:

The study will be performed on systemically healthy volunteer subjects screened for inclusion and exclusion criteria from the Outpatient Department, Department of Periodontics, at Dr HSRSM Dental College and Hospital, after obtaining an informed and written consent through signed document in English and local language to participate in the study.

Test Group:

Group A: Right maxillary quadrant will receive the PRF membrane application after gingival depigmentation.
Group B: Left maxillary quadrant will receive the PRFM gel application after gingival depigmentation.

Control Group:

Group C: The mandibular anterior sextant will receive only the periodontal dressing (co-pack) placement after gingival depigmentation.

IV. METHOD OF SELECTION OF STUDY SUBJECTS:

A written consent in English and regional local language with a detailed case history will be recorded from all 14 patients.

i. INCLUSION CRITERIA:

♦   Systemically and periodontally healthy male and female with an age range of 18–30 years.

♦   Patients with esthetic concern due to gingival hyperpigmentation.

♦   Patients with good oral hygiene, with the plaque index score of <1 and gingival index score <1, more than 2mm of attached gingiva.

♦   Diffuse continuous physiological pigmentation of the gingiva involving the facial aspect of teeth classified under Dummet Oral Pigmentation Index (DOPI), minimum score 2 (Moderate clinical pigmentation).

ii. EXCLUSION CRITERIA:

♦   Patients suffering from any known systemic diseases.

♦   Individuals with a habit of smoking/tobacco chewing.

♦   Alcoholic patients.

♦   Pregnant and lactating mothers.

♦   Patients suffering from neurological deficiency.

iii. SUBJECT WITHDRAWL CRITERIA

♦   Any subject meeting exclusion criteria during the study.

♦   Any subject willing to exit the study voluntarily.

♦   Any subject with adverse effects if any.

♦   If the subject cannot adhere to study timelines and appointments.

♦   Any subject developing any systemic disease during the study.

     Any subject withdrawing from the study shall be followed up indicated treatment as per their condition and shall be treated for any adverse effect if any.

      iv. SAMPLE SIZE:

     The total sample size for this study will be 42; with 14 samples in each study group.

V. METHOD OF MEASUREMENT

1. Dummet Oral Pigmentation Index (DOPI) (Dummet and Gupta, 1964)

2. Plaque index (PI) (Sillness and Loe, 1964)

3. Gingival Index (GI) (Loe and Sillness, 1963)

4. Visual analogue scale (VAS) for pain

5. Healing index (HI) (Landry et al, 1988)

6. Epithelialization Test

7. Histological Analysis

TREATMENT DETAILS:

Informed and written consent will be obtained from all patients and a detailed case history will be recorded. Periodontal status will be assessed using Plaque Index (Sillness & Loe, 1964), Gingival Index (Loe & Sillness, 1963). Physiological melanin pigmentation will be assessed using Dummet Oral Pigmentation Index (Dummet and Gupta, 1964).

The depigmentation procedure will be carried out by abrasion technique with the use of a precision soft tissue trimming ceramic bur under high-speed rpm without using water coolant spray. Due to friction, the heat which is produced by the bur causes immediate tissue coagulation and reduces bleeding, hence the use of coolant is avoided.  After the removal of the entire pigmented epithelium, saline will be used for irrigation.

Individuals will be divided into 3 groups based on the application of platelet concentrates following depigmentation procedure. 10 ml of blood samples will be withdrawn from antecubital vein from the individual.

Preparation of PRF membrane

5ml of blood transferred to glass vacutainer will be centrifuged at 2800 rpm for 12 min. The gel obtained following the centrifugation contains three layers. The top layer being platelet poor plasma and bottom layer consists of concentrated red blood cells. The middle layer harboured fibrin network gel will be compressed in between sterile gauze pieces, and the supernatant should be discarded to obtain PRF membrane.

The right maxillary quadrant will receive the PRF membrane. Membrane will be stabilized with 5-0 absorbable suture followed by periodontal dressing placement.

Preparation of PRFM gel

5ml of blood will be transferred to Meresis PRFM kit (Meresis, laboratory, Bangalore,
India) and will be centrifuged at rpm of 3000 for 10 min. The supernatant obtained at the top of gel will be removed to achieve the PRFM gel.

Left maxillary quadrant will receive the PRFM gel uniformly spread over depigmented epithelium followed by periodontal dressing placement.

Whereas the mandibular anterior sextant will receive only the periodontal dressing placement after depigmentation. The individuals are asked to refrain from brushing for 3 days following the procedure and will be instructed to rinse their mouth with 0.2% chlorhexidine digluconate mouthwash.

The clinical and histological parameters will be evaluated following the surgical procedure on 5th day, such as visual analog scale (VAS) and healing index (HI). All clinical parameters will be measured by an examiner other than surgeon.

 For epithelialization test, patient will be asked to rinse the mouth twice with water for 20 seconds to remove debris. Then 1% acetic acid will be applied for 20 seconds to remove ropey saliva, followed by 1% TB application for 20 seconds with cotton swab and stain uptake will be visualized. After the procedure 2 rinses with 1% acetic acid will be performed to reduce the extent of mechanically retained stain and the mouth will be rinsed with water.

Histological analysis will be carried out on 5th day through punch biopsy. Infiltrative anesthesia will be given in the buccal fold. The incision will be performed positioning the punch perpendicular and performing simultaneous rotational movements under gentle pressure to the depigmented gingival epithelium, from the lateral incisor region in maxillary arch and mandibular arch. Collected specimen will be transfer into 10% formalin fixative immediately after removal from the patient and will be send to laboratory. Patient is asked for consumption of analgesics if and when required after punch biopsy procedure. The patient will be recalled after 3 months for re-evaluation.


 
Close